DOSE·RESPONSE // evidence terminal

  weekly research bulletin  ·  est. 2026

The evidence behind what works.

An evidence terminal for clinicians. We screen the whole sports medicine, rehab & performance literature every week, appraise the papers that matter — and tell you what to do about them.

dose-response — subscribe --free
0
papers screened / wk
0
selected for issue
0
landmark paired
001
current issue
[01]

The method

find · appraise · sign-off

Most feeds tell you what a paper said. We tell you whether it’s any good, how big the effect really is, and whether it should change what you do on Monday. Summaries are everywhere. Judgement is rare.

01 · FIND

Every journal, every week

We harvest new and landmark research across sports medicine, rehab & performance — the whole literature, not a hand-picked handful — ranked by citation and field-weighted impact signals.

02 · APPRAISE

Critically, not credulously

Each paper gets the same rigorous read: risk of bias, effect size vs. clinical significance, the gap it doesn’t fill, and the landmark study it builds on or contradicts.

03 · SIGN-OFF

A clinician approves every word

Nothing ships on autopilot. A named clinical editor reviews and signs off every issue before it reaches you. Rigour is the product.

[02]

The lead

from this week’s issue

This is one paper, appraised. The same seven-field record every week — learn the shape once, read fast forever.

initialising record…
[03]

The five

the rest of what mattered

Free access shows the verdict line. Clinician members get the full appraisal on every record — plus the searchable archive.

[04]

Access

free to read · worth keeping
Specification
what you get
Free
£0
Clinician
£79/yr
Team
let’s talk
The Lead appraisal (full)
The Five — verdict lines
The Five — full appraisals
Latest + Landmark deep dives
Full searchable archive
CPD-loggable format
Multi-seat, shared archive
select access →
subscribe
enquire
[05]

Standards

a human signs off
“Statistically significant isn’t the same as significant. Our whole job is telling you the difference — and whether it changes anything.”
Appraisal, not summary
Risk of bias, effect size, generalisability. The judgement layer everyone else skips.
Latest + Landmark
Every new paper placed against the foundational study it builds on or overturns.
A human owns the verdict
AI reads at scale. A named clinician signs off. Nothing ships unreviewed.